Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Strategy for developing a safe and cost-effective H2-receptor antagonist program.

R A Quercia1, M S Chow, G T Jay

  • 1Hartford Hospital, CT 06115.

Hospital Formulary
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Colorimetric tetra-combo loop-mediated isothermal amplification assay for efficient SARS-CoV-2 detection.

Tropical biomedicine·2026
Same author

Antibiotic prophylaxis in eyes with filtration blebs: survey of glaucoma specialists, microbiological study, and recommendations.

Journal of glaucoma·2009
Same author

Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion.

Clinical drug investigation·2008
Same author

Cost analysis of fentanyl and remifentanil in coronary artery bypass graft surgery without cardiopulmonary bypass.

Journal of clinical pharmacy and therapeutics·2002
Same author

A medication assistance program to increase access to health-care.

Connecticut medicine·2002
Same author

Clinical management of respiratory tract infections in the community: experience with telithromycin.

Infection·2002
Same journal

Pharmaceutical industry wins "round one" in protections against product liability claims.

Hospital formulary·1995
Same journal

Safety, efficacy, and lipid profile of doxazosin at a VA medical center.

Hospital formulary·1995
Same journal

A team approach to adverse drug reaction surveillance: success at a tertiary care hospital.

Hospital formulary·1995
Same journal

The drive to reform the FDA gains momentum.

Hospital formulary·1995
Same journal

Who should conduct outcomes research?

Hospital formulary·1995
Same journal

The changing relationship between health care professionals and the pharmaceutical industry.

Hospital formulary·1995
See all related articles

A hospital transitioned to a capitation program using cimetidine, an H2-receptor antagonist, achieving significant cost savings. Safety concerns were managed, leading to broad staff support for the program.

Area of Science:

  • Pharmacoeconomics
  • Hospital Pharmacy Management
  • Drug Utilization

Background:

  • Community tertiary-care hospitals face pressures to optimize drug spending.
  • H2-receptor antagonists are commonly used, presenting opportunities for cost-saving initiatives.
  • Transitioning to new drug formularies requires careful evaluation of efficacy, safety, and cost.

Purpose of the Study:

  • To evaluate the efficacy and safety of cimetidine as a preferred H2-receptor antagonist in a hospital capitation program.
  • To assess the financial impact and cost savings associated with the drug formulary change.
  • To gauge staff acceptance and support for the mandatory capitation program.

Main Methods:

  • Pharmacy staff conducted a pre-transition evaluation of drug efficacy and safety.

Related Experiment Videos

  • A risk-management strategy was implemented to address safety concerns for high-risk patients.
  • Staff feedback and program outcomes were monitored post-transition.

    • Main Results:

    • The transition to a capitation program with cimetidine was successfully implemented.
    • Safety concerns were mitigated by allowing alternative drug use for specific patient groups.
    • Substantial annual cost savings were realized, encompassing labor, supplies, and acquisition costs.
    • Physician and nursing staff developed support for the program despite initial resistance.

    Conclusions:

    • A capitation program with cimetidine as the preferred H2-receptor antagonist is effective and safe.
    • Careful planning and risk management can facilitate successful drug formulary transitions.
    • Significant cost savings are achievable through strategic drug management in hospital settings.